Open Access

Journal of Molecular Medicine

, volume 99 , issue 2 , pages 303-310

An update to “novel therapeutic approaches for treatment of COVID-19”

Nikoo Hossein‐Khannazer ^{1, 2}

Bahare Shokoohian ^{3, 4}

Anastasia Shpichka ^{5, 6, 7}

Hamid Asadzadeh Aghdaei ⁸

Petr S. Timashev ^{5, 6, 7, 9}

Massoud Vosough ³

Hide authors affiliations Show authors affiliations: 9 affiliations

Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran |

Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran |

Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, Acecr, Tehran, Iran

Royan Institute

Academic Center for Education Culture and Research

⁴

Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical sciences, Tehran, Iran |

⁵

Institute for Regenerative Medicine, Sechenov University, Moscow, Russia |

⁶

Chemistry Department, Lomonosov Moscow State University, Moscow, Russia |

⁷

World-Class Research Center “Digital Biodesign and Personalized Healthcare”, Sechenov University, Moscow, Russia |

⁸

Department of Molecular Biology, Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran |

⁹

Department of Polymers and Composites, NN Semenov Institute of Chemical Physics, Moscow, Russia |

Publication type: Journal Article

Publication date: 2021-01-03

Springer Nature

Journal of Molecular Medicine

scimago Q1

wos Q1

SJR: 1.473

CiteScore: 9.4

Impact factor: 4.2

ISSN: 09462716, 14321440

DOI: 10.1007/s00109-020-02027-1

Copy DOI

PubMed ID: 33392632

Drug Discovery

Molecular Medicine

Genetics (clinical)

Abstract

Although the exact mechanism of pathogenesis in COVID-19 is not fully understood, cytokine storm following viral infection plays an important role in the initiation and progression of disease. SARS-CoV-2 infection induces over-activation of the immune system andmassive production of inflammatory cytokines. Therefore, it is necessary to develop new strategies to modulate inflammatory responses [1]. Despite many efforts to improve therapeutic protocols for COVID-19, there is no specific approved treatment or preventable vaccine for this disease [2, 3]. However, intensive research has been conducted to both prevent and treat COVID-19. This commentary is an update for our recent paper in “Journal of Molecular Medicine, June 2020” and highlights the recent achievements in terms of preventive and therapeutic approaches in COVID-19 [4].

Found

2 citations

Kosheleva N

PhD in Biological/biomedical sciences, associate professor

64 publications, 1 015 citations, 10 reviews

h-index: 18

Sechenov First Moscow State Medical University

Institute of General Pathology and Pathophysiology

Research interests

Developmental biology

1 citation

Bikmulina Polina

30 publications, 495 citations

h-index: 14

Sechenov First Moscow State Medical University

Research interests

3D bioprinting

3D cell culture

Top-30

Journals

	1 2
Journal of Molecular Medicine	Journal of Molecular Medicine, 2, 11.11% Journal of Molecular Medicine 2 publications, 11.11%
Vaccines	Vaccines, 2, 11.11% Vaccines 2 publications, 11.11%
Drug Discovery Today	Drug Discovery Today, 1, 5.56% Drug Discovery Today 1 publication, 5.56%
Bio-Design and Manufacturing	Bio-Design and Manufacturing, 1, 5.56% Bio-Design and Manufacturing 1 publication, 5.56%
Cells	Cells, 1, 5.56% Cells 1 publication, 5.56%
Antioxidants	Antioxidants, 1, 5.56% Antioxidants 1 publication, 5.56%
Frontiers in Immunology	Frontiers in Immunology, 1, 5.56% Frontiers in Immunology 1 publication, 5.56%
Frontiers in Cell and Developmental Biology	Frontiers in Cell and Developmental Biology, 1, 5.56% Frontiers in Cell and Developmental Biology 1 publication, 5.56%
Human Cell	Human Cell, 1, 5.56% Human Cell 1 publication, 5.56%
Value in Health	Value in Health, 1, 5.56% Value in Health 1 publication, 5.56%
International Immunopharmacology	International Immunopharmacology, 1, 5.56% International Immunopharmacology 1 publication, 5.56%
Biochimica et Biophysica Acta - General Subjects	Biochimica et Biophysica Acta - General Subjects, 1, 5.56% Biochimica et Biophysica Acta - General Subjects 1 publication, 5.56%
Drug Development and Industrial Pharmacy	Drug Development and Industrial Pharmacy, 1, 5.56% Drug Development and Industrial Pharmacy 1 publication, 5.56%
Journal of Clinical Psychopharmacology	Journal of Clinical Psychopharmacology, 1, 5.56% Journal of Clinical Psychopharmacology 1 publication, 5.56%
Stem Cell Research and Therapy	Stem Cell Research and Therapy, 1, 5.56% Stem Cell Research and Therapy 1 publication, 5.56%
GeroScience	GeroScience, 1, 5.56% GeroScience 1 publication, 5.56%
	1 2

Publishers

	1 2 3 4 5 6
Springer Nature	Springer Nature, 6, 33.33% Springer Nature 6 publications, 33.33%
Elsevier	Elsevier, 4, 22.22% Elsevier 4 publications, 22.22%
MDPI	MDPI, 4, 22.22% MDPI 4 publications, 22.22%
Frontiers Media S.A.	Frontiers Media S.A., 2, 11.11% Frontiers Media S.A. 2 publications, 11.11%
Taylor & Francis	Taylor & Francis, 1, 5.56% Taylor & Francis 1 publication, 5.56%
Ovid Technologies (Wolters Kluwer Health)	Ovid Technologies (Wolters Kluwer Health), 1, 5.56% Ovid Technologies (Wolters Kluwer Health) 1 publication, 5.56%
	1 2 3 4 5 6

We do not take into account publications without a DOI.
Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.

Metrics

Cite this

GOST |

Cite this

GOST Copy

Hossein‐Khannazer N. et al. An update to “novel therapeutic approaches for treatment of COVID-19” // Journal of Molecular Medicine. 2021. Vol. 99. No. 2. pp. 303-310.

GOST all authors (up to 50) Copy

Hossein‐Khannazer N., Shokoohian B., Shpichka A., Aghdaei H. A., Timashev P. S., Vosough M. An update to “novel therapeutic approaches for treatment of COVID-19” // Journal of Molecular Medicine. 2021. Vol. 99. No. 2. pp. 303-310.

RIS |

Cite this

RIS Copy

TY - JOUR

DO - 10.1007/s00109-020-02027-1

UR - https://doi.org/10.1007/s00109-020-02027-1

TI - An update to “novel therapeutic approaches for treatment of COVID-19”

T2 - Journal of Molecular Medicine

AU - Hossein‐Khannazer, Nikoo

AU - Shokoohian, Bahare

AU - Shpichka, Anastasia

AU - Aghdaei, Hamid Asadzadeh

AU - Timashev, Petr S.

AU - Vosough, Massoud

PY - 2021

DA - 2021/01/03

PB - Springer Nature

SP - 303-310

IS - 2

VL - 99

PMID - 33392632

SN - 0946-2716

SN - 1432-1440

ER -

BibTex |

Cite this

BibTex (up to 50 authors) Copy

@article{2021_Hossein‐Khannazer,

author = {Nikoo Hossein‐Khannazer and Bahare Shokoohian and Anastasia Shpichka and Hamid Asadzadeh Aghdaei and Petr S. Timashev and Massoud Vosough},

title = {An update to “novel therapeutic approaches for treatment of COVID-19”},

journal = {Journal of Molecular Medicine},

year = {2021},

volume = {99},

publisher = {Springer Nature},

month = {jan},

url = {https://doi.org/10.1007/s00109-020-02027-1},

number = {2},

pages = {303--310},

doi = {10.1007/s00109-020-02027-1}

}

MLA

Cite this

MLA Copy

Hossein‐Khannazer, Nikoo, et al. “An update to “novel therapeutic approaches for treatment of COVID-19”.” Journal of Molecular Medicine, vol. 99, no. 2, Jan. 2021, pp. 303-310. https://doi.org/10.1007/s00109-020-02027-1.

Publisher

Springer Nature

Journal

Journal of Molecular Medicine

scimago Q1

wos Q1

SJR

1.473

CiteScore

9.4

Impact factor

4.2

ISSN

09462716 (Print)

14321440 (Electronic)

Profiles